AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Solesence, Inc. Common Stock

$0.84 -$0.66 (-43.67%)
NASDAQ · 15 Sep 2026 17:42 UTC
Previous Close
$0.81
Day Range
$0.84$0.88
Year Range
$0.61$4.55
Market Cap
59.68M
AVG Volume
78.96K
Trailing/Forward PE
-31.79/-
PEG ratio
0.23
Dividend Yield
-
Next Earnings Date
2026-11-16
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
020M40M60M80M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q255.37M
26 Q160.4M
25 Q462.06M
25 Q362.15M
25 Q264.42M
25 Q157.1M
24 Q452.35M
24 Q347.79M
Net Income (USD) · TTM
-2M02M4M6M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-1.88M
26 Q1944K
25 Q41.79M
25 Q31.07M
25 Q25.23M
25 Q13.42M
24 Q44.24M
24 Q32.67M
Operating Income (USD) · TTM
-2M02M4M6M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-978K
26 Q1811K
25 Q41.57M
25 Q31.16M
25 Q25.14M
25 Q14.28M
24 Q45.13M
24 Q33.46M
EBITDA (USD) · TTM
02M4M6M8M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q291K
26 Q13.02M
25 Q43.69M
25 Q33.3M
25 Q27.29M
25 Q15.2M
24 Q46.06M
24 Q34.38M
Cash Flows (USD) · TTM
-15M-10M-5M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-1.81M
26 Q1-3.46M
25 Q4-11.67M
25 Q3-12.48M
25 Q2-6.75M
25 Q1-5.87M
24 Q4-2.59M
24 Q3-5.03M
EPS (USD) · TTM
-0.05-0.0300.030.050.0824 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.03
26 Q10.02
25 Q40.03
25 Q30.02
25 Q20.07
25 Q10.05
24 Q40.06
24 Q30.02
Expenses (USD) · TTM
05M10M15M20MR&DSG&ACapex24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q218.67M
26 Q118.82M
25 Q417.59M
25 Q318.52M
25 Q218.26M
25 Q116.18M
24 Q415.61M
24 Q312.6M
Shares Outstanding · TTM
-800K-600K-400K-200K024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SLSN Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
26 Q2-407K
26 Q1-448K
25 Q4-575K
25 Q3-617K
25 Q2-655K
25 Q1-692K
24 Q4-725K
24 Q3-477K
Employee Count
0501001502016201720182019202020212022202320242025
SLSN Employee Count by quarter
PeriodEmployee Count
2025115
202498
202379
202282
202158
202054
201953
201854
201748
201646
PE Ratio
050100150200med 69.31Jan 25Apr 25Jul 25Oct 25Jan 26May 26Aug 26
SLSN PE Ratio by quarter
PeriodPE Ratio
Aug 2676.31
Aug 2680.05
Jul 2662.12
Jul 2670.33
Jul 2657.98
Jul 2650.54
Jul 2651.06
Jun 2661.72
Jun 26100.25
Jun 2699.5
Jun 2698.01
May 2692.02
May 2693.52
May 2690.53
May 2653.22
May 2652.83
Apr 2647.7
Apr 2649.28
Apr 2643.76
Apr 2655.19
Mar 2659.9
Mar 2658.04
Mar 2662.32
Mar 2666.61
Feb 2684.42
Feb 2683.76
Feb 2687.71
Feb 2690.35
Jan 2689.03
Jan 2697.61
Jan 26100.9
Jan 2699.59
Jan 2698.93
Dec 25119.37
Dec 25134.54
Dec 25135.86
Dec 25135.2
Nov 25151.03
Nov 25145.75
Nov 25120.69
Nov 2539.41
Oct 2543.83
Oct 2549.59
Oct 2551.2
Oct 2547.72
Oct 2554.01
Sep 2544.36
Sep 2546.37
Sep 2545.17
Sep 2543.69
Aug 2549.06
Aug 2550.26
Aug 2552.27
Aug 2567.99
Aug 2556.93
Jul 2588.88
Jul 2581.72
Jul 2569.43
Jul 2580.9
Jun 2589.29
Jun 25106.7
Jun 2583.35
Jun 2578.64
May 2579.05
May 2576.6
May 2575.98
May 2556.19
May 2551.73
Apr 2541.15
Apr 2537.02
Apr 2529.09
Apr 2528.92
Mar 2554.78
Mar 2573.91
Mar 2569.72
Mar 2565.78
Feb 2574.17
Feb 2567.62
Feb 2575.22
Feb 2574.17
Jan 2577.05
Jan 2578.63
Jan 2569.19
Jan 2563.95
Jan 2561.33
Dec 2460.28
Dec 2464.21
Dec 2466.05
Dec 2471.55
Nov 2471.29
Nov 2469.45
Nov 2462.9
Free Cash Flow Yield
-25%-20%-15%-10%-5%0%med -3%Feb 25May 25Aug 25Nov 25Mar 26Jun 26Sep 26
SLSN Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-3.16%
Sep 26-3.16%
Sep 26-3.01%
Aug 26-2.69%
Aug 26-2.69%
Aug 26-4.8%
Aug 26-4.58%
Jul 26-5.9%
Jul 26-5.21%
Jul 26-6.32%
Jul 26-7.25%
Jul 26-7.17%
Jun 26-5.93%
Jun 26-3.65%
Jun 26-3.68%
Jun 26-3.74%
May 26-3.98%
May 26-3.92%
May 26-4.05%
May 26-12.25%
May 26-12.34%
Apr 26-13.67%
Apr 26-13.23%
Apr 26-14.9%
Apr 26-11.81%
Mar 26-19.49%
Mar 26-20.12%
Mar 26-18.74%
Mar 26-17.53%
Feb 26-13.83%
Feb 26-13.94%
Feb 26-13.31%
Feb 26-12.92%
Jan 26-13.12%
Jan 26-11.96%
Jan 26-11.57%
Jan 26-11.73%
Jan 26-11.8%
Dec 25-9.78%
Dec 25-8.68%
Dec 25-8.6%
Dec 25-8.64%
Nov 25-7.73%
Nov 25-8.01%
Nov 25-9.68%
Nov 25-3.28%
Oct 25-2.94%
Oct 25-2.6%
Oct 25-2.52%
Oct 25-2.7%
Oct 25-2.39%
Sep 25-2.91%
Sep 25-2.78%
Sep 25-2.86%
Sep 25-2.95%
Aug 25-2.63%
Aug 25-2.57%
Aug 25-2.47%
Aug 25-2.52%
Aug 25-3.01%
Jul 25-1.93%
Jul 25-2.1%
Jul 25-2.47%
Jul 25-2.12%
Jun 25-1.92%
Jun 25-1.61%
Jun 25-2.06%
Jun 25-2.18%
May 25-2.17%
May 25-2.24%
May 25-2.26%
May 25-1.09%
May 25-1.18%
Apr 25-1.48%
Apr 25-1.65%
Apr 25-2.1%
Apr 25-2.11%
Mar 25-3.45%
Mar 25-2.55%
Mar 25-2.71%
Mar 25-2.87%
Feb 25-2.54%
Feb 25-2.79%
Feb 25-2.51%
Feb 25-2.54%
Jan 25-2.45%
Jan 25-2.4%
Jan 25-2.73%
Jan 25-2.95%
Jan 25-3.08%
Dec 24-3.13%
Dec 24-2.94%
Dec 24-2.86%
Dec 24-2.64%
Nov 24-2.65%
Nov 24-2.72%
Nov 24-3%
Price to Sales
02468med 3.06Feb 25May 25Aug 25Nov 25Mar 26Jun 26Sep 26
SLSN Price to Sales by quarter
PeriodPrice to Sales
Sep 261.03
Sep 261.03
Sep 261.08
Aug 261.21
Aug 261.21
Aug 261.19
Aug 261.25
Jul 260.97
Jul 261.1
Jul 260.91
Jul 260.79
Jul 260.8
Jun 260.96
Jun 261.57
Jun 261.56
Jun 261.53
May 261.44
May 261.46
May 261.41
May 261.53
May 261.52
Apr 261.38
Apr 261.42
Apr 261.26
Apr 261.59
Mar 261.03
Mar 261
Mar 261.07
Mar 261.15
Feb 261.45
Feb 261.44
Feb 261.51
Feb 261.55
Jan 261.53
Jan 261.68
Jan 261.74
Jan 261.71
Jan 261.7
Dec 252.05
Dec 252.31
Dec 252.34
Dec 252.33
Nov 252.6
Nov 252.51
Nov 252.08
Nov 253.2
Oct 253.56
Oct 254.03
Oct 254.16
Oct 253.88
Oct 254.39
Sep 253.6
Sep 253.77
Sep 253.67
Sep 253.55
Aug 253.99
Aug 254.08
Aug 254.25
Aug 254.08
Aug 253.41
Jul 255.33
Jul 254.9
Jul 254.16
Jul 254.85
Jun 255.35
Jun 256.4
Jun 255
Jun 254.71
May 254.74
May 254.59
May 254.55
May 254.55
May 254.19
Apr 253.33
Apr 253
Apr 252.35
Apr 252.34
Mar 253.06
Mar 254.12
Mar 253.89
Mar 253.67
Feb 254.14
Feb 253.77
Feb 254.2
Feb 254.14
Jan 254.3
Jan 254.39
Jan 253.86
Jan 253.57
Jan 253.42
Dec 243.36
Dec 243.58
Dec 243.68
Dec 243.99
Nov 243.98
Nov 243.87
Nov 243.51
EV/EBITDA
02505007501000med 39.83Feb 25May 25Aug 25Nov 25Mar 26Jun 26Sep 26
SLSN EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 26866.78
Sep 26866.7
Sep 26897.06
Aug 26975.38
Aug 26975.38
Aug 2631.08
Aug 2632.25
Jul 2626.64
Jul 2629.21
Jul 2625.35
Jul 2623.02
Jul 2623.18
Jun 2626.52
Jun 2638.58
Jun 2638.34
Jun 2637.87
May 2636
May 2636.47
May 2635.53
May 2632.07
May 2631.88
Apr 2629.39
Apr 2630.15
Apr 2627.48
Apr 2633.02
Mar 2626.91
Mar 2626.3
Mar 2627.69
Mar 2629.08
Feb 2634.85
Feb 2634.63
Feb 2635.92
Feb 2636.77
Jan 2636.34
Jan 2639.12
Jan 2640.19
Jan 2639.76
Jan 2639.55
Dec 2546.17
Dec 2551.08
Dec 2551.51
Dec 2551.3
Nov 2556.42
Nov 2554.72
Nov 2546.6
Nov 2531.36
Oct 2534.54
Oct 2538.68
Oct 2539.83
Oct 2537.33
Oct 2541.86
Sep 2534.92
Sep 2536.37
Sep 2535.5
Sep 2534.44
Aug 2538.29
Aug 2539.16
Aug 2540.6
Aug 2548.77
Aug 2541.48
Jul 2562.52
Jul 2557.8
Jul 2549.71
Jul 2557.26
Jun 2562.79
Jun 2574.25
Jun 2558.88
Jun 2555.78
May 2556.05
May 2554.43
May 2554.03
May 2541.57
May 2538.45
Apr 2531.05
Apr 2528.17
Apr 2522.62
Apr 2522.51
Mar 2536.5
Mar 2548.15
Mar 2545.6
Mar 2543.2
Feb 2548.31
Feb 2544.32
Feb 2548.95
Feb 2548.31
Jan 2550.07
Jan 2551.02
Jan 2545.28
Jan 2542.08
Jan 2540.49
Dec 2439.85
Dec 2442.24
Dec 2443.36
Dec 2446.71
Nov 2446.55
Nov 2445.44
Nov 2441.45
Price/Operating Cashflow
0200400600med 281.88Apr 25May 25May 26Jun 26Jul 26Aug 26Sep 26
SLSN Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2656.32
Sep 2656.32
Sep 2659.03
Aug 2666.05
Aug 2666.05
Aug 26421.27
Aug 26441.93
Jul 26342.93
Jul 26388.23
Jul 26320.09
Jul 26278.99
Jul 26281.88
Jun 26340.74
Jun 26553.44
Jun 26549.31
Jun 26541.05
May 26508.01
May 26516.27
May 26499.75
May 25120.77
May 25111.18
Apr 2588.45
Apr 2579.57
Apr 2562.52
Apr 2562.16
Price to Book
0102030med 9.5Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SLSN Price to Book by quarter
PeriodPrice to Book
Sep 264.35
Sep 264.35
Sep 264.56
Aug 265.1
Aug 265.1
Aug 264.25
Aug 264.45
Jul 263.46
Jul 263.91
Jul 263.23
Jul 262.81
Jul 262.84
Jun 263.43
Jun 265.58
Jun 265.54
Jun 265.45
May 265.12
May 265.2
May 265.04
May 265.4
May 265.36
Apr 264.84
Apr 265
Apr 264.44
Apr 265.6
Mar 263.72
Mar 263.6
Mar 263.87
Mar 264.13
Feb 265.24
Feb 265.2
Feb 265.44
Feb 265.61
Jan 265.52
Jan 266.06
Jan 266.26
Jan 266.18
Jan 266.14
Dec 257.41
Dec 258.35
Dec 258.43
Dec 258.39
Nov 259.37
Nov 259.04
Nov 257.49
Nov 2511.34
Oct 2512.61
Oct 2514.27
Oct 2514.73
Oct 2513.73
Oct 2515.54
Sep 2512.77
Sep 2513.35
Sep 2513
Sep 2512.57
Aug 2514.12
Aug 2514.46
Aug 2515.04
Aug 2515.36
Aug 2512.86
Jul 2520.07
Jul 2518.46
Jul 2515.68
Jul 2518.27
Jun 2520.17
Jun 2524.1
Jun 2518.83
Jun 2517.76
May 2517.85
May 2517.3
May 2517.16
May 2515.93
May 2514.66
Apr 2511.66
Apr 2510.49
Apr 258.24
Apr 258.2
Mar 259.63
Mar 2512.99
Mar 2512.25
Mar 2511.56
Feb 2513.04
Feb 2511.88
Feb 2513.22
Feb 2513.04
Jan 2513.54
Jan 2513.82
Jan 2512.16
Jan 2511.24
Jan 2510.78
Dec 2410.59
Dec 2411.29
Dec 2411.61
Dec 2412.58
Nov 2412.53
Nov 2412.21
Nov 2411.06
Nov 249.08
Nov 248.37
Oct 247.32
Solesence, Inc. Common Stock
SLSN
Stockpicker

Video analysis: SLSN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SLSN

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

zacks.com · 25 Aug 2026

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

Solesence's Q2 results are pressured by higher operating expenses, but improving production efficiency and expectations for a stronger second half provide reasons for optimism.

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

seekingalpha.com · 19 Aug 2026

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

Solésence Reports Second Quarter 2026 Financial Results

globenewswire.com · 19 Aug 2026

Solésence Reports Second Quarter 2026 Financial Results

Please call Alissa Nakamoto at 216-509-9062 to confirm the details of the release. Please ensure that the release has the same distributions as past PRs.

Solésence Reschedules Second Quarter 2026 Conference Call to August 19

globenewswire.com · 10 Aug 2026

Solésence Reschedules Second Quarter 2026 Conference Call to August 19

ROMEOVILLE, Ill. , Aug. 10, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has rescheduled its second quarter 2026 conference call and webcast.

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

globenewswire.com · 28 Jul 2026

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date.

SLSN Unveils Two Scalp Care Products Using Patented Technology

zacks.com · 14 Jul 2026

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

globenewswire.com · 13 Jul 2026

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

globenewswire.com · 18 Jun 2026

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.